MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Spg 11 gene mutation associated autosomal recessive hereditary spastic paraplegia presenting with partially levodopa responsive parkinsonism, stereotypy and cognitive decline.

S. Desai, S. Singh, V. Patel, J. Sheth (Anand, India)

Meeting: 2017 International Congress

Abstract Number: 637

Keywords: Gait disorders: Genetics, Parkinsonism

Session Information

Date: Tuesday, June 6, 2017

Session Title: Rare Genetic and Metabolic Diseases

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To describe a rare case of SPG11 gene mutation associated complex hereditary spastic paraplegia with partially levodopa responsive parkinsonism

Background: Hereditary Spastic Paraplegia (HSP) is neurodegenerative disorder affecting primarily the long axonal fibers of the corticospinal tracts. Clinically they are classified into pure or complicated HSPs which have multiple accompanied features.  The exact clinical profile of SPG11 gene mutation associated complex HSP is still being described in literature. Majority of SPG11 gene mutation patients present with spastic paraplegia with cognitive involvement. Only three other case reports with associated partially levodopa responsive parkinsonism in patients with complex HSP associated with SPG11 mutation have been reported in literature

Methods: Case:A 33 year old male presented with history of regression with onset in second decade of life. He had normal birth and developmental milestones .At 15 years he developed gradually progressive spastic paraparesis associated with slowness and rigidity, followed by cognitive impairment with stereotypical movements and complex motor tics and became wheel chair bound by 25 years of age. There was no family history of similar symptoms or consanguinity.All the metabolic workup  and ophthalmologic evaluation was normal. MRI brain revealed mild thinning of corpus callosum and mild periventricular white matter changes.  He was partially responsive to levodopa at doses of up to 475 mg/day .

Results: All the metabolic workup  and ophthalmologic evaluation was normal. MRI brain revealed mild thinning of corpus callosum and mild periventricular white matter changes.  He was partially responsive to levodopa at doses of up to 475 mg/day .The diagnosis of hereditary spastic paraplegia was confirmed by genome sequencing which showed mutation in exon 11 of SPG 11 gene. 

Conclusions: Complex HSP due to SPG11 mutation should be also be considered in differential diagnosis of patients with young onset levodopa responsive Parkinsonism with spasticity and cognitive decline.

To cite this abstract in AMA style:

S. Desai, S. Singh, V. Patel, J. Sheth. Spg 11 gene mutation associated autosomal recessive hereditary spastic paraplegia presenting with partially levodopa responsive parkinsonism, stereotypy and cognitive decline. [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/spg-11-gene-mutation-associated-autosomal-recessive-hereditary-spastic-paraplegia-presenting-with-partially-levodopa-responsive-parkinsonism-stereotypy-and-cognitive-decline/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/spg-11-gene-mutation-associated-autosomal-recessive-hereditary-spastic-paraplegia-presenting-with-partially-levodopa-responsive-parkinsonism-stereotypy-and-cognitive-decline/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley